- Value
- Analytics
- Backtesting
- Options
- Resources
Go Prime
My Profile
My Dashboard
My Watchlist
My Alerts
My Portfolio
Share a Trial
Change Password
Logout
Price Table
Date | Open | High | Low | Close | Volume | Delivery % | 20-Day sma | 50-Day sma | 200-Day sma |
---|---|---|---|---|---|---|---|---|---|
13 Mar, 2025 | 29800.00 | 30112.80 | 29556.55 | 29597.00 | 5,268 | 22.61 | 29949.85 | 28736.10 | 28404.00 |
12 Mar, 2025 | 30520.00 | 30679.95 | 29555.55 | 29795.85 | 11,266 | 36.39 | 29909.00 | 28743.35 | 28387.25 |
11 Mar, 2025 | 30620.10 | 31103.80 | 30394.30 | 30496.50 | 9,378 | 25.83 | 29875.65 | 28747.80 | 28369.25 |
10 Mar, 2025 | 30768.30 | 31099.95 | 30125.00 | 30629.60 | 11,926 | 28.63 | 29835.00 | 28732.70 | 28347.30 |
07 Mar, 2025 | 30990.00 | 31597.80 | 30630.65 | 30768.30 | 12,123 | 36.62 | 29793.50 | 28716.15 | 28325.15 |
06 Mar, 2025 | 31500.00 | 31573.25 | 30659.30 | 30983.15 | 15,991 | 43.86 | 29709.15 | 28686.10 | 28303.50 |
05 Mar, 2025 | 31539.90 | 31898.95 | 30854.45 | 31448.10 | 20,717 | 36.71 | 29550.10 | 28638.35 | 28281.05 |
View More
Day High Low Range
Time | Lowest | Highest | Volume |
---|---|---|---|
09.30 AM | 29635.20 | 29967.00 | 761.00 |
09.45 AM | 29635.20 | 30031.95 | 1147.00 |
10 AM | 29635.20 | 30090.85 | 1389.00 |
11 AM | 29635.20 | 30112.80 | 2264.00 |
12 PM | 29635.20 | 30112.80 | 3343.00 |
1 PM | 29635.20 | 30112.80 | 3672.00 |
2 PM | 29635.20 | 30112.80 | 3961.00 |
3 PM | 29572.20 | 30112.80 | 4594.00 |
Past Performance & Moving Averages
Day’s | Low high range | SMA | Stock performance | Nifty performance |
---|---|---|---|---|
10 DAY | 29115.00 - 31898.95 | 30683.76 | 0.23% | 2.12% |
20 DAY | 27549.90 - 31898.95 | 29949.85 | 3.73% | -1.1% |
50 DAY | 25325.00 - 31898.95 | 28736.12 | 8.65% | -2.22% |
100 DAY | 25325.00 - 31898.95 | 28634.15 | 6.53% | -7.45% |
200 DAY | 25325.00 - 31898.95 | 28404.02 | 4.06% | -9.67% |
YTD | 25325.00 - 31898.95 | 28784.3 | 0.63% | -4.64% |
52 Week | 25200.00 - 31898.95 | 28052.22 | 8.04% | -7.3% |
PIVOT POINTS
NAME | S4 | S3 | S2 | S1 | PIVOT POINTS | R1 | R2 | R3 | R4 |
---|---|---|---|---|---|---|---|---|---|
CLASSIC | - | 28216.55 | 28886.05 | 29340.95 | 30010.45 | 30465.35 | 31134.85 | 31589.75 | - |
WOODIE‘S | - | - | 28832.40 | 29233.65 | 29956.80 | 30358.05 | 31081.20 | - | - |
FIBONACCI | - | 28886.05 | 29315.35 | 29580.93 | 30010.45 | 30439.97 | 30705.55 | 31134.85 | - |
CAMARILLA | 29177.43 | 29486.64 | 29589.71 | 29692.78 | - | 29898.92 | 30001.99 | 30105.06 | 30414.27 |
CPR Levels
- ABBOTINDIA is currently trading Below CPR levels which signifies Bearishness.
- Today's CPR is comparatively Wider and unlikely to make a trending move today.
- Day's opening range is 29635.2 ~ 29967.
- Price is currently trading Inside the day's opening range.
Trend Analysis
Key Data
Market cap | Book value | stock p/e | Dividend yield | roce | roe | sales growth (3Y) | face value (3Y) |
---|---|---|---|---|---|---|---|
62970.34 CR. | 1741.00 | 49.10 | 1.48% | 46.00% | 34.90% | 11.00% | 10.00 |
Profile
Abbott India Limited is a subsidiary of Abbott Laboratories, a global healthcare company based in the United States. The company was established in India in 1910 and is headquartered in Mumbai. Abbott India operates in the healthcare and pharmaceutical industry, offering a wide range of products and services including medical devices, diagnostics, and prescription drugs.
In terms of financials, Abbott India has shown strong performance over the years, with revenue and profits consistently growing. The company's primary sources of revenue come from the sale of prescription drugs and medical devices.
Abbott India operates in a highly competitive market, competing against other multinational and domestic pharmaceutical companies such as Pfizer, Novartis, and Cipla.
Here is a brief SWOT analysis for Abbott India:
Strengths:
- Strong brand recognition and reputation in the healthcare industry
- Extensive product portfolio, including both prescription drugs and medical devices
- Strong research and development capabilities
Weaknesses:
- Dependence on a limited number of key products for revenue
- Exposure to regulatory and compliance risks in the highly regulated healthcare industry
- Vulnerability to changes in government policies and regulations
Opportunities:
- Expansion into new and emerging markets
- Growing demand for healthcare products and services, especially in developing countries
- Development of new and innovative products to meet the changing needs of customers
Threats:
- Intense competition from established players in the industry
- Changes in government regulations and policies, such as taxes and import duties
- Potential for patent expirations and increased generic competition.
Please note that this is a general analysis and may not accurately reflect the current state of the company. It's important to conduct thorough research and consult with a financial advisor before making any investment decisions.
